Tilray Medical, a medical cannabis division of Tilray Brands, Inc.,TLRY TLRY has launched Take Back Control, a new platform developed to connect women with free resources on medical cannabis and to help destigmatize the use of medical cannabis in women’s healthcare practices. The Take Back Control platform connects people with free consultations with healthcare practitioners focused on women’s health providing expert advice on medical cannabis.
Take Back Control is designed to help women make informed decisions about medical cannabis and assists them along their path to discovering how medical cannabis can play a part in their daily healthcare practices. Available now in Canada, Take Back Control simplifies the steps to meet with a healthcare practitioner to help women through their needs and challenges, providing professional guidance to help kick-start their medical cannabis health care journey.
Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.
Photo by Thiago Patriota on Unsplash
Related News
Charlotte's Web Reports 2022 Third Quarter Financial Results
Aurora Cannabis: What Makes Upside Potential For This Pot Stock? Analyst Has An Idea
Tilray's CANACA Launches 3 New High-Potency Full-Spectrum Butane Hash Oil Infused Products
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.